Chemistry Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$856K Hold
714
0.14% 101
2026
Q1
$657K Sell
714
-23
-3% -$23.3K 0.12% 105
2025
Q4
$792K Sell
737
-50
-6% -$47.8K 0.15% 96
2025
Q3
$600K Buy
787
+143
+22% +$106K 0.12% 106
2025
Q2
$502K Buy
644
+18
+3% +$14K 0.11% 109
2025
Q1
$517K Sell
626
-108
-15% -$89.9K 0.12% 99
2024
Q4
$567K Sell
734
-87
-11% -$72K 0.13% 94
2024
Q3
$727K Buy
821
+130
+19% +$117K 0.17% 82
2024
Q2
$626K Buy
691
+141
+26% +$113K 0.16% 83
2024
Q1
$428K Buy
550
+24
+5% +$17.1K 0.12% 104
2023
Q4
$307K Hold
526
0.09% 127
2023
Q3
$283K Buy
+526
New +$271K 0.09% 126

Other funds holding LLY

Chemistry Wealth Management's LLY Position: Q2 2026 in Review

Chemistry Wealth Management held its Eli Lilly (LLY) position steady in Q2 2026 at 714 shares worth $856K. The position accounts for 0.14% of the portfolio, ranked #101.

Chemistry Wealth Management first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Chemistry Wealth Management held 714 shares of Eli Lilly worth $856K as of Q2 2026.
  • Chemistry Wealth Management left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.14% of Chemistry Wealth Management's portfolio in Q2 2026, its #101 holding.
  • Chemistry Wealth Management first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Chemistry Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.